Janux Therapeutics Inc. (JANX)
NASDAQ: JANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
JANX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.10B
- EPS (TTM)
- -$1.64
- Dividend yield
- None
- 52-week range
- 12.12 – 35.34
- Day range
- 16.42 – 18.37
- Volume / Avg
- 1.21M / 830.67K
- Beta
- —
- Shares outstanding
- 61.14M
- Next earnings
- Nov 5, 2026
52-week range
JANX stock today
Janux Therapeutics (JANX) closed at $17.92 on Oct 7, up 6.73% (+$1.13), versus the S&P 500's 0.22% decline. Shares are 49.3% below their 52-week high of $35.34, set on Nov 26, 2025 and 47.9% above the 52-week low of $12.12, in the middle of the past year's range. JANX is up 29.9% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 21.0%.
Janux Therapeutics has posted a net loss over the last twelve months (EPS of -$1.64), so its P/E ratio is not meaningful. Janux Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Janux Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.45
JANX news
All JANX newsJanux Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TRAXFirst Tracks Biotherapeutics Inc. | 30.59 | -2.55% | $1.09B | vs JANX |
| LBRXLB Pharmaceuticals Inc | 34.16 | -0.29% | $1.10B | vs JANX |
| BCAXBicara Therapeutics Inc. | 16.42 | -0.85% | $1.09B | vs JANX |
| AMPHAmphastar Pharmaceuticals Inc. | 25.54 | -1.43% | $1.09B | vs JANX |
| MNKDMannKind Corporation | 3.45 | -7.01% | $1.11B | vs JANX |
| AVLNAvalyn Pharma Inc. | 25.53 | +0.39% | $1.13B | vs JANX |
| HROWHarrow Inc. | 30.62 | +0.89% | $1.15B | vs JANX |
| OPKOPKO Health Inc. | 1.39 | -4.79% | $1.04B | vs JANX |
Indexes, lists and sector
Janux Therapeutics stock FAQ
What is Janux Therapeutics's stock price today?
JANX last traded at $17.92 as of Oct 7, 4:00 PM EDT, up 6.73% on the day. Prices are delayed at least 15 minutes.
When is Janux Therapeutics's next earnings date?
Janux Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.45.
What is the JANX 52-week high?
The 52-week high for JANX is $35.34 and the 52-week low is $12.12. The stock is currently 49.3% below its high.